Literature DB >> 17035440

Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception.

M Diane Lougheed1, Thomas Fisher, Denis E O'Donnell.   

Abstract

OBJECTIVE: The objective of this study was to examine the relationship between respiratory symptom intensity and quality and dynamic lung hyperinflation (DH) during induced bronchoconstriction in asthma. PATIENTS AND METHODS: Subjects with asthma (n = 116) underwent baseline spirometry and lung volume measurement followed by high-dose methacholine challenge testing (MCT) [maximum decrease in FEV(1) of 50% from baseline]. Dyspnea intensity (Borg scale) was measured after each dose of methacholine. Qualitative descriptors of breathlessness and functional residual capacity (FRC) were measured at the doses nearest to the provocative concentration of methacholine causing a 20% fall in FEV (PC(20)) and at the highest dose of methacholine (maximum response).
RESULTS: FEV(1) decreased by 24.7 +/- 0.7% (mean +/- SEM) at the dose nearest to PC(20) and by 46.1 +/- 1.1% at maximum response. Inspiratory capacity decreased by 0.62 +/- 0.04 L at the dose nearest to PC(20) and 1.06 +/- 0.06 L at maximum response. The descriptor clusters "inspiratory difficulty," "chest tightness," "unsatisfied inspiration," and "work" were selected at the dose nearest to PC(20) but were more frequently selected at maximum response (p < 0.0001). Individuals who reported chest tightness at maximum response had greater airflow obstruction and higher FRC (percentage of predicted) than those who did not report chest tightness.
CONCLUSIONS: Four dominant qualities of dyspnea in asthma (inspiratory difficulty, chest tightness, unsatisfied inspiration, and work) were reported early in the course of MCT and evolved in parallel, becoming more prevalent at maximum response. Significant DH accompanied even mild bronchoconstriction during MCT in asthma, making it difficult to separate mechanisms of chest tightness from other dominant respiratory sensations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035440     DOI: 10.1378/chest.130.4.1072

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  15 in total

Review 1.  Cough variant asthma: lessons learned from deep inspirations.

Authors:  M Diane Lougheed; Scott E Turcotte; Thomas Fisher
Journal:  Lung       Date:  2011-12-03       Impact factor: 2.584

2.  A Multidimensional Profile of Dyspnea in Hospitalized Patients.

Authors:  Jennifer P Stevens; Andrew R Sheridan; Heather B Bernstein; Kathy Baker; Robert W Lansing; Richard M Schwartzstein; Robert B Banzett
Journal:  Chest       Date:  2019-05-22       Impact factor: 9.410

3.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

4.  Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice.

Authors:  Rafael Marino; Thusanth Thuraisingam; Pierre Camateros; Cynthia Kanagaratham; Yong Zhong Xu; Jennifer Henri; Jingxuan Yang; Guoan He; Aihao Ding; Danuta Radzioch
Journal:  J Immunol       Date:  2011-02-18       Impact factor: 5.422

5.  Differing reports of asthma symptoms in African Americans and Caucasians.

Authors:  D Scott Trochtenberg; Rhonda BeLue; Sharon Piphus; Niketa Washington
Journal:  J Asthma       Date:  2008-03       Impact factor: 2.515

6.  Aerosolized methacholine-induced bronchoconstriction and pulmonary hyperinflation in rats.

Authors:  Tetsuri Kondo; Toshimori Tanigaki; Chizuko Tsuji; Hiroshi Ishii; Gen Tazaki; Yuusuke Kondo
Journal:  J Physiol Sci       Date:  2009-06-09       Impact factor: 2.781

7.  Chest CT abnormalities and quality of life: relationship in adult cystic fibrosis.

Authors:  Aoife Kilcoyne; Lisa P Lavelle; Colin J McCarthy; Sinead H McEvoy; Hannah Fleming; Annika Gallagher; Martine Loeve; Harm Tiddens; Edward McKone; Charles C Gallagher; Jonathan D Dodd
Journal:  Ann Transl Med       Date:  2016-03

8.  Descriptors of dyspnea in obstructive lung diseases.

Authors:  Sabina A Antoniu
Journal:  Multidiscip Respir Med       Date:  2010-06-30

9.  Vital capacity and inspiratory capacity as additional parameters to evaluate bronchodilator response in asthmatic patients: a cross sectional study.

Authors:  Karen S Azevedo; Ronir R Luiz; Patricia Rm Rocco; Marcus B Conde
Journal:  BMC Pulm Med       Date:  2012-09-05       Impact factor: 3.317

10.  Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics.

Authors:  Julia K L Walker; Monica Kraft; John T Fisher
Journal:  Front Physiol       Date:  2013-02-12       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.